Acute Central Retinal Artery Occlusion Seen within 24 Hours at a Tertiary Institution

• Authors: Wesley Chan, Emory University; Alexis M Flowers, Emory University; Benjamin Meyer, Emory University; Beau Bruce, Emory University; Nancy Newman, Emory University; Valerie Biousse, Emory University
• Journal Title: JOURNAL OF STROKE & CEREBROVASCULAR DISEASES
• Volume: Volume 30, Number 9
• Publisher: ELSEVIER | 2021-07-13, Pages 105988-105988
• Type of Work: Article | Post-print: After Peer Review
• Publisher DOI: http://doi.org/10.1016/j.jstrokecerebrovasdis.2021.105988
• Subjects: Health Sciences, Epidemiology; Health Sciences, Medicine and Surgery
• Keywords: Science & Technology; Life Sciences & Biomedicine; Neurosciences; Peripheral Vascular Disease; Neurosciences & Neurology; Cardiovascular System & Cardiology; Central retinal artery occlusion; Intravenous thrombolysis;   Stroke; Vision; THERAPY; TIME

Abstract

Objective: Acute central retinal artery occlusion (CRAO) is an emergency with poor visual outcome. Intravenous thrombolysis within 4.5 h of vision loss is safe and may improve vision, but is rarely administered because of frequent delays in presentation. We describe a subgroup of CRAO patients presenting within 24 h of vision loss to a tertiary care center affiliated with a comprehensive stroke center. Materials and Methods: Retrospective review of 181 consecutive CRAO patients seen at our institution from 2010 to 2020. Results: Out of 181 CRAO patients, 62 (34%) presented within 24 h of vision loss and tended to live closer to the hospital. These patients were more likely to be admitted to the hospital and receive comprehensive stroke work-up compared to patients who presented after 24 h of vision loss. Patients presenting after 24 h did not necessarily receive prior appropriate work-up at outside institutions. Conservative treatments for CRAO were administered to 20/181 patients, and only 3 patients received intravenous thrombolysis. Conclusions: Patients with CRAO do not present to the emergency department fast enough and diagnosis of CRAO is often delayed. Despite having a protocol in place, only 3/181 patients received IV thrombolysis, emphasizing the difficulty in administering very acute treatments for CRAO. Public education regarding CRAO is necessary to improve presentation times, management, and visual outcomes. Hospitals need to develop accelerated diagnostic pathway protocols for patients with acute vision loss so that CRAO patients may be diagnosed and be considered for potential acute treatments as quickly as possible.